United Therapeutics (UTHR) Insider Discloses September Stock Sales Totaling 60,000 Shares

Rhea-AI Filing Summary

UNITED THERAPEUTICS (UTHR) Form 144: This notice reports a proposed sale of 4,000 common shares through TD Securities (USA) LLC with an aggregate market value of $1,702,446.76 and shows 60,000 shares sold by Martine Rothblatt across multiple dates in September 2025. The filing records that 294,000 shares were originally acquired on 03/15/2016 under an executive deferred compensation arrangement and that the acquisition involved exercised vested options paid via common shares. The issuer has approximately 45,230,000 shares outstanding. The filer certifies no undisclosed material adverse information.

Insights

Corporate Governance Expert

TL;DR: Insider sales disclosed; amount represents a small fraction of outstanding shares and appears procedural.

The filing documents routine insider sales by Martine Rothblatt totaling 60,000 shares sold across September dates and a new proposed sale of 4,000 shares. Given the issuer's ~45.23 million shares outstanding, the recent dispositions represent roughly 0.13% of the float, suggesting limited dilution or corporate control impact. The disclosure includes acquisition details showing shares originated from executive deferred compensation and exercised options, which is relevant for governance review of insider liquidity events.

Securities Analyst

TL;DR: Insider selling activity is visible but not material to market cap; monitor execution timing and proceeds.

The Form 144 quantifies proposed and recent sales with specific proceeds per trade, enabling assessment of realized insider liquidity. Aggregate market value of the proposed 4,000-share sale is reported as $1,702,446.76, and a series of prior September sales generated multi-million-dollar proceeds per trade. While proceeds are sizable in absolute dollars, relative to outstanding shares the transactions are small, implying limited immediate impact on supply-demand dynamics.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	TD SECURITIES (USA) LLC 125 PARK AVE, 20th Floor NEW YORK NY 10017	4000	1702446.76	45230000	09/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	03/15/2016	Executive Deferred Compensation	Martine Rothblatt			294000	03/15/2016	Shares exercised via vested options and payment made via common shares

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/09/2025	8000	3188374.33
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/10/2025	4000	1594872.82
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/11/2025	4000	1588904.00
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/12/2025	4000	1615897.79
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/15/2025	4000	1591535.70
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/16/2025	4000	1601062.04
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/17/2025	4000	1600686.85
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/18/2025	4000	1617665.13
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/19/2025	4000	1644310.00
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/22/2025	4000	1669212.50
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/23/2025	4000	1672512.50
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/24/2025	4000	1736408.50
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/25/2025	4000	1723659.00
Martine Rothblatt 1000 Spring Street Silver Spring MD 20910	Common	09/26/2025	4000	1712811.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the UTHR Form 144 disclose about proposed sales?

The filing discloses a proposed sale of 4,000 common shares through TD Securities (USA) LLC with an aggregate market value of $1,702,446.76.

How many shares did Martine Rothblatt sell in September 2025?

The Form 144 lists sales totaling 60,000 common shares across multiple dates in September 2025.

How many shares does the issuer have outstanding according to the filing?

The filing reports approximately 45,230,000 shares outstanding.

What is the origin of the shares being sold?

The securities were acquired on 03/15/2016 under an executive deferred compensation arrangement and involved exercised vested options paid via common shares.

Who is the broker named for the proposed sale?

The broker listed for the proposed transaction is TD Securities (USA) LLC at 125 Park Ave, New York.